4//SEC Filing
Huntsman Ronald Kirk 4
Accession 0001493152-20-024277
CIK 0001716166other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:53 PM ET
Size
7.0 KB
Accession
0001493152-20-024277
Insider Transaction Report
Form 4
Huntsman Ronald Kirk
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2020-12-23$7.27/sh+1,000$7,267→ 1,500 total
Holdings
- 333,334
Stock Option
Exercise: $1.65Exp: 2022-09-30→ Common Stock (333,334 underlying) - 1,749,000(indirect: See Note)
Common Stock
Footnotes (3)
- [F1]1,000 shares purchased in prices ranging from $7.25 through $7.2798 per share.
- [F2]Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835498
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 6:53 PM ET
- Size
- 7.0 KB